Guido Rasi Takes Office As Head Of European Medicines Agency

Professor Guido Rasi has taken office as Executive Director of the European Medicines Agency (EMA) today.

Professor Rasi was nominated as Executive Director for a five-year mandate by the Management Board of the Agency on 1 October 2015. He was appointed following his statement to the European Parliament's Committee on Environment, Public Health and Food Safety (ENVI) on 13 October 2015.

"I am very happy to be back at the helm of the Agency," said Professor Rasi on his first day in office. "We are currently undergoing the most significant transformation of the system of medicine development and authorisation that I have seen during my 35-year career in public health, either as a doctor, a researcher or a regulator. It is exciting and challenging to be leading the Agency during this time."

Press briefing with Guido Rasi: Wednesday, 9 December

Professor Rasi will outline his priorities for the next five years to representatives of the media at a virtual press briefing to be held on Wednesday, 9 December at 14:00 GMT. Please reply to [email protected] before close of business on Monday, 7 December to register for this briefing. We will then send you log-in details prior to the briefing.

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.